Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

EVORA European Viral Outbreak Response Alliance

Coordinator
Universite D'aix Marseille, France
Runs
1 January 2024 to 31 December 2026
Status
Running
EU funding
€4.9m
Total cost
—
Partners
21 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101131959

What the project is doing

In the project's own words, from its summary on CORDIS.

COVID-19 has highlighted the need for EU preparedness towards the growing number of virus outbreaks. Research infrastructures are strategic tools for providing resources and access to technologies for research, promoting innovation and supporting public health actions, but their impact is limited when they operate individually. The European Viral Outbreak Research Alliance (EVORA) project brings together three RIs (EVA, ERINHA-ESFRI and ELIXIR-ESFRI) with unique and complementary expertise in bio-banking, high containment facilities and data management solutions, respectively, under a single concerted interoperable framework with a common and long-term perspective.

EVORA aims to strengthen EU capacity for concerted preparedness and response to viral diseases, unify RI operations to achieve optimal RI responsiveness, sustainability and worldwide competitiveness and address specific regulatory, ethical, and security challenges related to emerging pathogens. EVORA will create synergies between the RIs through common governance and concerted decision-making mechanisms. The interoperability of EVORA services will be integrated, through unified operational procedures and quality standards, in order to support user needs and EU Health-Tech in either “inter-crisis” or “viral emergence response” conditions.

Finally, the project will address the complex regulatory aspects of preclinical research involving high-risk pathogens, to ensure the operability of the structure. By paving the way for a sustainable alliance of state-of-the-art RIs for preparedness and response to viral emergence, EVORA will strengthen the cohesiveness of the RI landscape in the field, contribute to the competitiveness of the European Research Area (ERA), and ultimately improve the EU's resilience to emerging communicable diseases.

Topics

Who is involved

OrganisationCityCountryRole
Universite D'aix MarseilleMarseilleFranceCoordinator
Medizinische Universitat GrazGrazAustriaThird party
European Research Infrastructure on Highly Pathogenic AgentsBruxelles / BrusselBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumThird party
Vib VzwZwijnaarde - GentBelgiumThird party
Bernhard-Nocht-Institut Fuer TropenmedizinHamburgGermanyParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer TiergesundheitGreifswald-Insel RiemsGermanyParticipant
Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbHBraunschweigGermanyParticipant
Instituto De Salud Carlos IiiMadridSpainThird party
Institut National De La Sante Et De La Recherche MedicaleParisFranceThird party
Institut PasteurParisFranceParticipant
Protisvalor Mediterranee SASMarseilleFranceThird party
Nemzeti Nepegeszsegugyi Es Gyogyszereszeti KozpontBudapestHungaryThird party
Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura a Carattere ScientificoRomaItalyThird party
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsThird party
Rijksinstituut Voor Volksgezondheid En Milieu (rivm)BilthovenNetherlandsParticipant
Instituto Nacional De Saude Dr. Ricardo JorgeLisboaPortugalThird party
FolkhalsomyndighetenSolnaSwedenThird party
Univerza V LjubljaniLjubljanaSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI